Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19

Juan Corchado-Garcia, David Puyraimond-Zemmour, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O’Horo, Gregory J. Gores, Amy W. Williams, Andrew D. Badley, John Halamka, Abinash Virk, Melanie D. Swift, Tyler Wagner, Venky Soundararajan
doi: https://doi.org/10.1101/2021.04.27.21256193

Article Information

doi 
https://doi.org/10.1101/2021.04.27.21256193
History 
  • April 30, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Juan Corchado-Garcia1,+,
  2. David Puyraimond-Zemmour1,+,
  3. Travis Hughes1,
  4. Tudor Cristea-Platon1,
  5. Patrick Lenehan1,
  6. Colin Pawlowski1,
  7. Sairam Bade2,
  8. John C. O’Horo3,
  9. Gregory J. Gores3,
  10. Amy W. Williams3,
  11. Andrew D. Badley3,
  12. John Halamka3,
  13. Abinash Virk3,
  14. Melanie D. Swift3,
  15. Tyler Wagner1,* and
  16. Venky Soundararajan1,2,*
  1. 1nference, One Main Street, East Arcade, Cambridge, MA 02142, USA
  2. 2nference Labs, 2ndFloor, 22 3rdCross Rd, Murgesh Pallya, Bengaluru, Karnataka 560017, India
  3. 3Mayo Clinic, Rochester, MN 55902, USA
  1. ↵*Correspondence: Tyler Wagner (tyler{at}nference.net), Venky Soundararajan (venky{at}nference.net)
Back to top
Posted April 30, 2021.
Download PDF
Data/Code
Email
Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19
Juan Corchado-Garcia, David Puyraimond-Zemmour, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O’Horo, Gregory J. Gores, Amy W. Williams, Andrew D. Badley, John Halamka, Abinash Virk, Melanie D. Swift, Tyler Wagner, Venky Soundararajan
medRxiv 2021.04.27.21256193; doi: https://doi.org/10.1101/2021.04.27.21256193
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area